These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2887045)

  • 41. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA-DR genotyping by restriction fragment length polymorphism analyses.
    Hui K; Festenstein H; de Klein A; Grosveld G; Grosveld F
    Immunogenetics; 1985; 22(3):231-9. PubMed ID: 2995247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serologic HLA-DR typing is not sufficient for definition of class II compatibility.
    Möller E; Carlsson B; Wallin J
    Transplant Proc; 1988 Jun; 20(3):375-6. PubMed ID: 2898178
    [No Abstract]   [Full Text] [Related]  

  • 44. Progression of HIV-related disease is associated with HLA DQ and DR alleles defined by restriction fragment length polymorphisms.
    Donald JA; Rudman K; Cooper DW; Baumgart KW; Garsia RJ; Gatenby PA; Rickard KA
    Tissue Antigens; 1992 May; 39(5):241-8. PubMed ID: 1357776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The chimpanzee major histocompatibility complex class II DR subregion contains an unexpectedly high number of beta-chain genes.
    Bontrop RE; Broos LA; Pham K; Bakas RM; Otting N; Jonker M
    Immunogenetics; 1990; 32(4):272-80. PubMed ID: 1978714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLA-DR4-associated haplotypes are genotypically diverse within HLA.
    Holbeck SL; Kim SJ; Silver J; Hansen JA; Nepom GT
    J Immunol; 1985 Jul; 135(1):637-41. PubMed ID: 2987355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restriction fragment length polymorphism (RFLP) heterogeneity of HLA-DQ beta genes associated with DNA fragment identical to the DR1-beta DNA structure.
    Redford A; Magalong D; Onohara-Toyoda M; Tyan D; Riley WJ; Maclaren NK; Rotter JI; Toyoda H
    Dis Markers; 1991; 9(5):257-63. PubMed ID: 1686750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA-DR expression in a human colonic carcinoma cell line.
    Lampert IA; Kirkland S; Farrell S; Borysiewicz LK
    J Pathol; 1985 Aug; 146(4):337-44. PubMed ID: 3928856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The HLA-Dw HAG specificity is defined by DR beta cDNA hybridization as a hybrid haplotype carrying DR5 and DRw6 determinants.
    Tilanus MG; Schreuder GM; Pawelec G; Giphart MJ
    Tissue Antigens; 1987 Mar; 29(3):168-72. PubMed ID: 2440146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allogenotypes defined by short DQ alpha and DQ beta cDNA probes correlate with and define splits of HLA-DQ serological specificities.
    Bidwell JL; Bidwell EA; Laundy GJ; Klouda PT; Bradley BA
    Mol Immunol; 1987 May; 24(5):513-22. PubMed ID: 2889137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T-cell recognition of HLA class II molecules induced by gamma-interferon on a colonic adenocarcinoma cell line (HT29).
    Lundin KE; Sollid LM; Bosnes V; Gaudernack G; Thorsby E
    Scand J Immunol; 1990 Apr; 31(4):469-75. PubMed ID: 2110380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of HLA-DR allospecificities on antigen specific T cell clones.
    Igarashi M; Suciu-Foca N; Ferrone S
    Tissue Antigens; 1987 Mar; 29(3):160-7. PubMed ID: 2440145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA-DR and -DQ DNA genotyping in seven populations of Asia-Oceania and Australia.
    Kohonen-Corish MR; Dunckley H; Serjeantson SW
    Tissue Antigens; 1988 Jul; 32(1):32-40. PubMed ID: 2903582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymorphism of HLA-DR beta chains in DR4, -7, and -9 haplotypes: implications for the mechanisms of allelic variation.
    Gregersen PK; Moriuchi T; Karr RW; Obata F; Moriuchi J; Maccari J; Goldberg D; Winchester RJ; Silver J
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9149-53. PubMed ID: 3466180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential expression of the HLA-DR genes in various melanoma cell lines treated with interferon-gamma: methylation of the HLA-DR alpha gene in these lines is not correlated with its expression.
    Carrington MN; Chedid M; Ting JP; Ward FE
    Hum Immunol; 1987 Feb; 18(2):151-61. PubMed ID: 3104241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of HLA-DR phenotypes and T-lymphocyte-receptor beta-chain-region RFLP with IDDM in Japanese.
    Ito M; Tanimoto M; Kamura H; Yoneda M; Morishima Y; Takatsuki K; Itatsu T; Saito H
    Diabetes; 1988 Dec; 37(12):1633-6. PubMed ID: 2903835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of HLA-DR antigens with disease severity in Japanese patients with rheumatoid arthritis.
    Doita M; Hirohata K; Maeda S
    Kobe J Med Sci; 1990 Aug; 36(3-4):103-14. PubMed ID: 1982890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cultured human fetal astrocytes can be induced by interferon-gamma to express HLA-DR.
    Pulver M; Carrel S; Mach JP; de Tribolet N
    J Neuroimmunol; 1987 Mar; 14(2):123-33. PubMed ID: 3102554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HLA class II genes polymorphism in DR4 giant cell arteritis patients.
    Bignon JD; Ferec C; Barrier J; Pennec Y; Verlingue C; Cheneau ML; Lucas V; Muller JY; Saleun JP
    Tissue Antigens; 1988 Nov; 32(5):254-8. PubMed ID: 2906182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HLA-DR antigens and HLA-DQ beta chain polymorphism in susceptibility to rheumatoid arthritis.
    Ilonen J; Reijonen H; Arvilommi H; Jokinen I; Möttönen T; Hannonen P
    Ann Rheum Dis; 1990 Jul; 49(7):494-6. PubMed ID: 1974413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.